氯喹在抗击 COVID-19 中的作用：好、坏，还是皆有？
Chloroquine in fighting COVID-19: good, bad, or both?
机构信息
The Third Affiliated Hospital, Guangzhou Medical University , Guangzhou, Guangdong, China.
Department of Surgery, UT Southwestern Medical Center , Dallas, TX, USA.
出版信息
Autophagy. 2020 Dec;16(12):2273-2275. doi: 10.1080/15548627.2020.1796014. Epub 2020 Jul 25.
Abstract
Coronavirus disease 2019 (COVID-19) has attracted worldwide attention due to its speed of progression and elevated mortality rate. Amid the rush to develop treatments, recent hopes have focused on the anti-malarial drug chloroquine or the derivative hydroxychloroquine. Here, we briefly discuss the evidence for the potential use of these drugs with regard to the current pandemic.
摘要
新型冠状病毒病 2019（COVID-19）由于其进展速度和高死亡率而引起了全世界的关注。在急于开发治疗方法的过程中，最近的希望集中在抗疟药氯喹或其衍生物羟氯喹上。在这里，我们简要讨论了这些药物在当前大流行中的潜在用途的证据。
相似文献
1
Chloroquine in fighting COVID-19: good, bad, or both?氯喹在抗击 COVID-19 中的作用：好、坏，还是皆有？
Autophagy. 2020 Dec;16(12):2273-2275. doi: 10.1080/15548627.2020.1796014. Epub 2020 Jul 25.
2
Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: hope or hype?利用自噬调节药物对抗 SARS-CoV-2：希望还是炒作？
Autophagy. 2020 Dec;16(12):2267-2270. doi: 10.1080/15548627.2020.1779531. Epub 2020 Jun 19.
3
Chloroquine and its derivatives in the management of COVID-19: A scoping review.氯喹及其衍生物在COVID-19治疗中的应用：一项范围综述。
Biomedica. 2020 Oct 30;40(Supl. 2):80-95. doi: 10.7705/biomedica.5478.
4
Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine.自噬作为 COVID-19 的新兴靶点：来自老朋友氯喹的启示。
Autophagy. 2020 Dec;16(12):2260-2266. doi: 10.1080/15548627.2020.1779467. Epub 2020 Jun 24.
5
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
6
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
7
Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.羟氯喹和氯喹在 COVID-19 患者中的应用：随机临床试验的荟萃分析。
Pathog Glob Health. 2021 May;115(3):139-150. doi: 10.1080/20477724.2021.1884807. Epub 2021 Feb 11.
8
Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic.新型冠状病毒肺炎大流行期间与使用羟氯喹和氯喹相关的药物不良反应报告
Ann Intern Med. 2021 Jun;174(6):878-880. doi: 10.7326/M20-7918. Epub 2021 Jan 26.
9
Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.氯喹和羟氯喹治疗 COVID-19 的紧急授权。
Ann Pharmacother. 2020 Aug;54(8):827-831. doi: 10.1177/1060028020925558. Epub 2020 May 9.
10
Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19.事实与误区：重新利用氯喹和羟氯喹治疗 COVID-19 的疗效。
Curr Drug Targets. 2020;21(16):1703-1721. doi: 10.2174/1389450121666200617133142.
引用本文的文献
1
Designing a molecularly imprinted polymer-based electrochemical sensor for the sensitive and selective detection of the antimalarial chloroquine phosphate.设计一种基于分子印迹聚合物的电化学传感器，用于灵敏和选择性地检测抗疟药磷酸氯喹。
Mikrochim Acta. 2024 Nov 13;191(12):741. doi: 10.1007/s00604-024-06820-4.
2
Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment.达芦那韦乙醇酸盐：将一种抗艾滋病毒药物用于新冠肺炎治疗的新用途。
Eur J Med Chem Rep. 2021 Dec;3:100013. doi: 10.1016/j.ejmcr.2021.100013. Epub 2021 Oct 22.
3
MERS-CoV nsp1 regulates autophagic flux via mTOR signalling and dysfunctional lysosomes.中东呼吸综合征冠状病毒 nsp1 通过 mTOR 信号通路和功能失调的溶酶体来调节自噬流。
Emerg Microbes Infect. 2022 Dec;11(1):2529-2543. doi: 10.1080/22221751.2022.2128434.
4
Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19.敌友难分：自噬溶酶体途径在 SARS-CoV-2 感染与 COVID-19 中的作用。
Int J Biol Sci. 2022 Jul 11;18(12):4690-4703. doi: 10.7150/ijbs.72544. eCollection 2022.
5
Autophagy in health and disease: From molecular mechanisms to therapeutic target.健康与疾病中的自噬：从分子机制到治疗靶点
MedComm (2020). 2022 Jul 10;3(3):e150. doi: 10.1002/mco2.150. eCollection 2022 Sep.
6
Safety considerations of chloroquine in the treatment of patients with diabetes and COVID-19.氯喹治疗糖尿病合并 COVID-19 患者的安全性考虑。
Chem Biol Interact. 2022 Jul 1;361:109954. doi: 10.1016/j.cbi.2022.109954. Epub 2022 Apr 22.
7
One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview.巴西的 2019 冠状病毒病（COVID-19）一年：政治和社会概述。
Ann Glob Health. 2021 May 18;87(1):44. doi: 10.5334/aogh.3182.
8
Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.治疗方案对 SARS-CoV-2 冠状病毒抗体反应的影响。
Front Immunol. 2021 Apr 15;12:580147. doi: 10.3389/fimmu.2021.580147. eCollection 2021.
9
HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.高迁移率族蛋白B1作为重症新型冠状病毒肺炎的潜在生物标志物和治疗靶点。
Heliyon. 2020 Dec 7;6(12):e05672. doi: 10.1016/j.heliyon.2020.e05672. eCollection 2020 Dec.
10
A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19.一项包含 676 名患者的队列研究表明，D-二聚体是 COVID-19 患者死亡的一个关键危险因素。
PLoS One. 2020 Nov 9;15(11):e0242045. doi: 10.1371/journal.pone.0242045. eCollection 2020.
本文引用的文献
1
The hallmarks of COVID-19 disease.新型冠状病毒疾病的特征。
PLoS Pathog. 2020 May 22;16(5):e1008536. doi: 10.1371/journal.ppat.1008536. eCollection 2020 May.
2
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
4
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19.一项关于氯喹治疗 COVID-19 的疗效和安全性的系统评价。
J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10.
5
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
6
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.氯喹和羟氯喹作为对抗新型冠状病毒肺炎的现有武器。
Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.
7
Structure analysis of the receptor binding of 2019-nCoV.2019新型冠状病毒受体结合的结构分析
Biochem Biophys Res Commun. 2020 Feb 17;525(1):135-40. doi: 10.1016/j.bbrc.2020.02.071.
8
[Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia].《磷酸氯喹治疗新型冠状病毒肺炎专家共识》
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 20;43(0):E019. doi: 10.3760/cma.j.issn.1001-0939.2020.0019.
9
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
10
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
Zotero 插件